Document summarizing the beneficiaries strategy related to the dissemination and exploitation of the project resultsREsolution has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034439. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. This article reflects only the authors' views and neither IMI nor the European Union and EFPIA are responsible for any use that may be made of the information contained therein
This document presents DynaLearn’s dissemination and communication plan in the context of a methodol...
This document arises from the NANOGENOTOX Joint Action which has received funding from the European ...
This plan for the dissemination and exploitation of the results (PEDR) provides the basis for EuroMi...
Initial version of DMPREsolution has received funding from the Innovative Medicines Initiative 2 Joi...
Updated version of DMP at midtermREsolution has received funding from the Innovative Medicines Initi...
The following document is the Deliverable 5.4 “Dissemination and Exploitation Plan” (DEP) of the PUR...
This document includes a description of the strategy for the dissemination of the project results. ...
This deliverable summarises the beneficiaries’ strategy and concrete actions related to the protecti...
Summary The current Plan summarises the beneficiaries’ strategy and concrete actions related to the...
This Deliverable presents the ARETE Dissemination plan, in line with the communication approach. The...
An.Dy Dissemination and Exploitation Plan (D6.1)Publication developed within the An.Dy project, fund...
The Exploitation and Dissemination Plan aims to present all the key exploitable results generated on...
This document is a deliverable of the Co-UDlabs project, funded under the European Union’s Horizon 2...
The present document summarises the beneficiaries’ strategy and concrete actions related to the expl...
The present Dissemination, Communication and Exploitation plan is prepared within the Dissemination,...
This document presents DynaLearn’s dissemination and communication plan in the context of a methodol...
This document arises from the NANOGENOTOX Joint Action which has received funding from the European ...
This plan for the dissemination and exploitation of the results (PEDR) provides the basis for EuroMi...
Initial version of DMPREsolution has received funding from the Innovative Medicines Initiative 2 Joi...
Updated version of DMP at midtermREsolution has received funding from the Innovative Medicines Initi...
The following document is the Deliverable 5.4 “Dissemination and Exploitation Plan” (DEP) of the PUR...
This document includes a description of the strategy for the dissemination of the project results. ...
This deliverable summarises the beneficiaries’ strategy and concrete actions related to the protecti...
Summary The current Plan summarises the beneficiaries’ strategy and concrete actions related to the...
This Deliverable presents the ARETE Dissemination plan, in line with the communication approach. The...
An.Dy Dissemination and Exploitation Plan (D6.1)Publication developed within the An.Dy project, fund...
The Exploitation and Dissemination Plan aims to present all the key exploitable results generated on...
This document is a deliverable of the Co-UDlabs project, funded under the European Union’s Horizon 2...
The present document summarises the beneficiaries’ strategy and concrete actions related to the expl...
The present Dissemination, Communication and Exploitation plan is prepared within the Dissemination,...
This document presents DynaLearn’s dissemination and communication plan in the context of a methodol...
This document arises from the NANOGENOTOX Joint Action which has received funding from the European ...
This plan for the dissemination and exploitation of the results (PEDR) provides the basis for EuroMi...